We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Ranitidine Recalled Due to Potential Carcinogen Contamination

News   Oct 21, 2019 | Original story from the Medicines and Healthcare products Regulatory Agency

 
Ranitidine Recalled Due to Potential Carcinogen Contamination

Credit: Pixabay

 
 
 

RELATED ARTICLES

Safety and Efficacy Results From CRISPR/Cas9 Human Clinical Trials Are Positive

News

CRISPR Therapeutics and Vertex Pharmaceuticals have announced their interim safety and efficacy results from the CTX001 CRISPR/Cas9 gene-editing human clinical trials - and they're promising.

READ MORE

A Milestone Is Reached For New Leukemia Drug

News

Cold Spring Harbor Laboratory scientists, with chemists and cancer biologists from Dana-Farber Cancer Institute (DFCI), have developed a new therapy that extended the survival of mice with acute myeloid leukemia.

READ MORE

New Database Could Help Identify Therapeutic Targets for the Creation of Antibiotics

News

Researchers have created a database called "BacFITBase" which characterizes bacterial genes relevant to the infection process in live organisms. The new database aims to aid the discovery of novel therapeutic targets for the creation of antibiotics.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE